Featured Post

Wednesday Women's Health in the News: Most Frequently Asked Questions On MonaLisa Touch Vaginal Therapy

MonaLisa Touch: The Issue of Vaginal Symptoms Even with the passage of time, many women still retain their youthful energy and enthusi...

Menopause: Making Peace With Change

Wednesday, February 27, 2013

Medication for Painful Intercourse Newly Approved by the FDA!

Osphena is a newly approved prescription medication for menopausal women with painful intercourse. Painful intercourse, or dysparunia, in menopausal women is due to the thinning and dryness of the vaginal walls. If a woman is experiencing more than painful intercourse it is called the post-menopausal vulvovaginal syndrome. The active ingredient in Osphena is ospemifene which was studied in three clinical trials. It is related to estrogen, and thus it is possible that it will thicken the lining tissue of the uterus. any women with post menopausal bleeding needs to contact her health care provider regarding that symptoms. Women who are using medication for vaginal atrophy. The Women's Health Practice Clinical Research Division wants to thank our research trial participants in the research trials for ospemifene, and hope they hear about the successful treatment. The medication can cause some vaginal discharge, and some women reported hot flashes and muscle spasms. The risk of having a deep vein blood clot with this medication is low, but the  risk is raised over the natural risks when not on the medication.

No comments:

Post a Comment

Thank you for your comments and questions. This blog is not intended to replace medical care, but is informational only. We hope you will become a follower or visit Womens Health Practice. We offer a variety of unique services including MonaLisa Touch, Coolsculpting, Labiaplasty, and Gynecoloigic Clinical Research Trials. For more information on menopause see http://www.amazon.com/Menopause-Make-Peace-Change

Follow on Twitter

Follow GynoGab on Twitter

Vaginal Contraceptive Ring

If you are a female between the ages of 18 and 35 you may be eligible for a contraceptive ring investigational contraceptive medication study. Qualified participants will receive study-related medical evaluations and care at no cost. If interested, please call 217-356-3736.

There was an error in this gadget

Gab ON!

Ciao, from Gyno Gab Gal! Send me questions and thoughts and let me know what is important to you! Hope to hear from you often.

Join one of our studies, become a patient at Women's Health Practice, come for an event, or visit any one of my websites our FB https://www.facebook.com/pages/Womens-Health-Practice/149858581724556?ref=hl

Women's Health Practice
Hada Cosmetic Medicine

Follow Women's Health Practice and Hada Cosmetic Medicine on Facebook https://www.facebook.com/pages/Hada-Cosmetic-Medicine/68631517372?fre!

Follow GynoGab on Twitter!

Adult Vaccination Recommendations